HTGM Annual CFO
-$18.41 M
-$1.90 M-11.50%
31 December 2022
Summary:
As of January 21, 2025, HTGM annual cash flow from operations is -$18.41 million, with the most recent change of -$1.90 million (-11.50%) on December 31, 2022. During the last 3 years, it has fallen by -$1.71 million (-10.25%).HTGM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HTGM Quarterly CFO
-$4.36 M
-$2.34 M-115.68%
31 March 2023
Summary:
As of January 21, 2025, HTGM quarterly cash flow from operations is -$4.36 million, with the most recent change of -$2.34 million (-115.68%) on March 31, 2023. Over the past year, it has increased by +$1.58 million (+26.53%).HTGM Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HTGM TTM CFO
-$16.83 M
+$1.58 M+8.56%
31 March 2023
Summary:
As of January 21, 2025, HTGM TTM cash flow from operations is -$16.83 million, with the most recent change of +$1.58 million (+8.56%) on March 31, 2023. Over the past year, it has increased by +$1.26 million (+6.98%).HTGM TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HTGM Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -11.5% | +26.5% | +7.0% |
| 3 y3 years | -10.3% | -11.0% | -12.0% |
| 5 y5 years | -11.1% | -61.5% | -0.8% |
HTGM Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | +112.1% | +115.7% | +344.8% |
HTG Molecular Diagnostics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$4.36 M(+115.7%) | -$16.83 M(-8.6%) |
| Dec 2022 | -$18.41 M(+11.5%) | -$2.02 M(-56.0%) | -$18.41 M(-6.9%) |
| Sept 2022 | - | -$4.60 M(-21.4%) | -$19.77 M(+2.0%) |
| June 2022 | - | -$5.85 M(-1.5%) | -$19.40 M(+7.2%) |
| Mar 2022 | - | -$5.94 M(+75.2%) | -$18.09 M(+9.6%) |
| Dec 2021 | -$16.51 M(+1.3%) | -$3.39 M(-19.6%) | -$16.51 M(-1.0%) |
| Sept 2021 | - | -$4.22 M(-7.3%) | -$16.67 M(-0.8%) |
| June 2021 | - | -$4.55 M(+4.5%) | -$16.81 M(+0.6%) |
| Mar 2021 | - | -$4.35 M(+22.6%) | -$16.72 M(+2.6%) |
| Dec 2020 | -$16.29 M(-2.4%) | -$3.55 M(-18.5%) | -$16.29 M(-1.8%) |
| Sept 2020 | - | -$4.36 M(-2.1%) | -$16.60 M(+1.8%) |
| June 2020 | - | -$4.45 M(+13.3%) | -$16.31 M(+8.5%) |
| Mar 2020 | - | -$3.93 M(+1.9%) | -$15.03 M(-10.0%) |
| Dec 2019 | -$16.70 M(+26.7%) | -$3.86 M(-5.3%) | -$16.70 M(+8.3%) |
| Sept 2019 | - | -$4.07 M(+28.3%) | -$15.41 M(+3.2%) |
| June 2019 | - | -$3.17 M(-43.3%) | -$14.93 M(-7.0%) |
| Mar 2019 | - | -$5.59 M(+117.2%) | -$16.07 M(+22.0%) |
| Dec 2018 | -$13.17 M | -$2.58 M(-28.3%) | -$13.17 M(-1.9%) |
| Sept 2018 | - | -$3.59 M(-16.6%) | -$13.42 M(-4.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2018 | - | -$4.31 M(+59.4%) | -$13.99 M(-4.5%) |
| Mar 2018 | - | -$2.70 M(-4.4%) | -$14.64 M(-11.7%) |
| Dec 2017 | -$16.57 M(-25.5%) | -$2.83 M(-32.0%) | -$16.57 M(-11.2%) |
| Sept 2017 | - | -$4.15 M(-16.2%) | -$18.67 M(-1.2%) |
| June 2017 | - | -$4.96 M(+6.9%) | -$18.90 M(-8.9%) |
| Mar 2017 | - | -$4.64 M(-5.8%) | -$20.75 M(-6.7%) |
| Dec 2016 | -$22.23 M(+15.5%) | -$4.92 M(+12.3%) | -$22.23 M(+1.7%) |
| Sept 2016 | - | -$4.38 M(-35.6%) | -$21.87 M(-0.5%) |
| June 2016 | - | -$6.81 M(+11.2%) | -$21.98 M(+4.9%) |
| Mar 2016 | - | -$6.12 M(+34.4%) | -$20.95 M(+8.9%) |
| Dec 2015 | -$19.24 M(+48.1%) | -$4.56 M(+1.5%) | -$19.24 M(+10.2%) |
| Sept 2015 | - | -$4.49 M(-22.4%) | -$17.46 M(+5.5%) |
| June 2015 | - | -$5.78 M(+31.0%) | -$16.55 M(+21.5%) |
| Mar 2015 | - | -$4.41 M(+59.2%) | -$13.63 M(+4.9%) |
| Dec 2014 | -$13.00 M(+9.9%) | -$2.77 M(-22.6%) | -$13.00 M(+27.1%) |
| Sept 2014 | - | -$3.58 M(+25.4%) | -$10.22 M(+53.9%) |
| June 2014 | - | -$2.86 M(-24.5%) | -$6.64 M(+75.5%) |
| Mar 2014 | - | -$3.78 M | -$3.78 M |
| Dec 2013 | -$11.82 M(+36.2%) | - | - |
| Dec 2012 | -$8.68 M | - | - |
FAQ
- What is HTG Molecular Diagnostics annual cash flow from operations?
- What is the all time high annual CFO for HTG Molecular Diagnostics?
- What is HTG Molecular Diagnostics annual CFO year-on-year change?
- What is HTG Molecular Diagnostics quarterly cash flow from operations?
- What is the all time high quarterly CFO for HTG Molecular Diagnostics?
- What is HTG Molecular Diagnostics quarterly CFO year-on-year change?
- What is HTG Molecular Diagnostics TTM cash flow from operations?
- What is the all time high TTM CFO for HTG Molecular Diagnostics?
- What is HTG Molecular Diagnostics TTM CFO year-on-year change?
What is HTG Molecular Diagnostics annual cash flow from operations?
The current annual CFO of HTGM is -$18.41 M
What is the all time high annual CFO for HTG Molecular Diagnostics?
HTG Molecular Diagnostics all-time high annual cash flow from operations is -$8.68 M
What is HTG Molecular Diagnostics annual CFO year-on-year change?
Over the past year, HTGM annual cash flow from operations has changed by -$1.90 M (-11.50%)
What is HTG Molecular Diagnostics quarterly cash flow from operations?
The current quarterly CFO of HTGM is -$4.36 M
What is the all time high quarterly CFO for HTG Molecular Diagnostics?
HTG Molecular Diagnostics all-time high quarterly cash flow from operations is -$2.02 M
What is HTG Molecular Diagnostics quarterly CFO year-on-year change?
Over the past year, HTGM quarterly cash flow from operations has changed by +$1.58 M (+26.53%)
What is HTG Molecular Diagnostics TTM cash flow from operations?
The current TTM CFO of HTGM is -$16.83 M
What is the all time high TTM CFO for HTG Molecular Diagnostics?
HTG Molecular Diagnostics all-time high TTM cash flow from operations is -$3.78 M
What is HTG Molecular Diagnostics TTM CFO year-on-year change?
Over the past year, HTGM TTM cash flow from operations has changed by +$1.26 M (+6.98%)